News 2011

arGEN-X raises mio 27.5 Euro in an oversubscribed series B financing round

Date: 01/12/2011

Rotterdam, The Netherlands – arGEN-X announced today that it has closed an oversubscribed series B financing round of 27.5 mio Euro (more…)

Thuja and DCPrime: Publication in “Het Financieele Dagblad”

Date: 28/11/2011

Utrecht, The Netherlands – The Dutch financial newspaper “Het Financieele Dagblad” today published an article on Thuja Capital and DCPrime. (more…)

Galapagos’ GLPG0634 shows excellent efficacy and safety in rheumatoid arthritis Phase II study

Date: 22/11/2011

Mechelen, Belgium – Galapagos reports that its JAK1 inhibitor GLPG0634 shows excellent efficacy and safety (more…)

Thuja Capital Healthcare Seed Fund invests in Akeso Medical Imaging B.V.

Date: 20/09/2011

Utrecht, The Netherlands – Thuja Capital announces today its latest investment in Akeso Medical Imaging B.V. (more…)

Thuja Capital Healthcare Fund invests in TheraSolve N.V.

Date: 22/08/2011

Utrecht, The Netherlands – Thuja Capital announces today its latest investment, in Therasolve N.V. (more…)

Avantium raises EUR 30 million to advance YXY technology

Date: 09/06/2011

Amsterdam, The Netherlands – Avantium raises EUR 30 million to advance YXY technology. Read full press release here.

Galapagos initiates second Proof of Mechanism clinical study in GSK alliance

Date: 11/05/2011

Mechelen, Belgium – Galapagos initiates second Proof of Mechanism clinical study in GSK alliance. Read the full article here.

Avantium spins out its pharmaceutical business

Date: 19/04/2011

Amsterdam, The Netherlands – Avantium spins out its pharmaceutical business. (more…)

Thuja Capital Healthcare Seed Fund invests in NightBalance B.V.

Date: 18/04/2011

Utrecht, The Netherlands – Thuja announced today that is has closed an investment in NightBalance (more…)

Galapagos discontinues Phase II trial

Date: 15/04/2011

Mechelen, Belgium – Galapagos announced today that is has stopped its Phase II clinical trial for GLP0259. (more…)

DCPrime initiates its first clinical study in AML patients

Date: 14/04/2011

Amsterdam, The Netherlands – DCPrime announced today that it initiated a clinical study with its first candidate therapeutic cancer vaccine. (more…)

Abbott and Enanta present positive Phase 2 study data

Date: 04/04/2011

Boston, USA – Abbott and Enanta present positive 12-week results and 3-day resistance data (more…)

DSMB recommends continuation of Curacyte’s Phase III PHOENIX trial

Date: 28/03/2011

Munich, Germany – Cyracyte announced today that the PHOENIX Phase III trial of PHP (more…)

Galapagos starts Phase 1b clinical study in cancer patients

Date: 14/03/2011

Mechelen, Belgium –  Galapagos announced today that it starts a Phase 1b clinical study in cancer patients. More information here.

Galapagos reports record revenues and increased profitability in 2010

Date: 04/03/2011

Mechelen, Belgium – Galapagos reports record revenues and increased profitability in 2010 (more…)

Thuja Capital sells its stake in Bioceros

Date: 17/02/2011

Utrecht, The Netherlands – Thuja Capital has sold its stake in Bioceros and has as such realized a first exit in the Thuja Capital Healthcare Fund. More details in the press release.

arGEN-X signs discovery and development alliance with Lilly

Date: 04/01/2011

Rotterdam, The Netherlands – arGEN-X signs discovery and development alliance with Lilly (more…)